OP
MRNA icon

ORG Partners’s Moderna MRNA Stock Holding History

ORG Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.44K Sell
83
-319
-79% -$8.67K ﹤0.01% 1401
2025
Q3 		$10.4K Buy
402
+365
+986% +$10.2K ﹤0.01% 965
2025
Q2 		$1.06K Sell
37
-79
-68% -$2.08K ﹤0.01% 1327
2025
Q1 		$3.14K Buy
116
+34
+41% +$1.21K ﹤0.01% 1012
2024
Q4 		$3.39K Buy
82
+34
+71% +$1.63K ﹤0.01% 1043
2024
Q3 		$3.18K Sell
48
-3
-6% -$275 ﹤0.01% 921
2024
Q2 		$5.88K Buy
51
+42
+467% +$5.32K ﹤0.01% 1358
2024
Q1 		$947 Buy
9
+2
+29% +$202 ﹤0.01% 448
2023
Q4 		$695 Sell
7
-47
-87% -$3.95K ﹤0.01% 1026
2023
Q3 		$5.56K Sell
54
-3
-5% -$335 ﹤0.01% 932
2023
Q2 		$7.34K Buy
+57
New +$7.6K ﹤0.01% 1025

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

ORG Partners's MRNA Position: Q4 2025 in Review

ORG Partners reduced its Moderna (MRNA) stake by 79% in Q4 2025, selling an estimated $8.67K and leaving 83 shares worth $2.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1401.

ORG Partners first reported a position in MRNA in Q2 2023 and has held it in 11 quarters since. The position peaked at $10.4K in Q3 2025. 672 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • ORG Partners held 83 shares of Moderna worth $2.44K as of Q4 2025.
  • ORG Partners sold 319 Moderna shares in Q4 2025, an estimated $8.67K.
  • Moderna made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1401 holding.
  • ORG Partners first reported a position in Moderna in Q2 2023 and has held it in 11 quarters since.
  • ORG Partners's Moderna position peaked at $10.4K in Q3 2025.
  • 672 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.